Lexaurin

Bromazepam, the active ingredient in Lexaurin, is a benzodiazepine presented as an oral tablet for oral use. It is prescribed for the short‑term relief of anxiety symptoms in adults. GNH USA supplies Lexaurin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Bromazepam belongs to the benzodiazepine class and is used to manage anxiety‑related conditions. - Generalized anxiety disorder: reduces excessive worry and tension. - Panic disorder: lessens the frequency and intensity of panic attacks. - Situational anxiety (e.g., before medical procedures): provides short‑term calming effect.

Bromazepam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: sensation of light‑headedness or unsteadiness. - Impaired coordination: reduced motor control and balance. - Headache: mild to moderate cranial pain. - Memory impairment: difficulty recalling recent events. - Fatigue: persistent lack of energy.

Serious or Rare Side Effects: - Depression or suicidal thoughts: mood changes requiring immediate medical attention. - Respiratory depression: slowed breathing, especially with other CNS depressants. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Paradoxical agitation: increased anxiety or aggression. - Withdrawal seizures: risk if the drug is stopped abruptly after prolonged use.

Bromazepam requires careful use and monitoring to minimise risks. - Discontinue gradually: avoid abrupt cessation to prevent withdrawal symptoms. - Hepatic impairment: dose adjustment may be needed in liver disease. - Avoid alcohol: combined use can intensify sedation and respiratory depression. - Pregnancy Category D: potential risk to the fetus; use only if clearly needed. - Elderly patients: increased sensitivity to sedative effects; start with the lowest effective dose. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Bromazepam can interact with several drug classes, altering its safety profile.

Major Interactions (Avoid): - Alcohol: additive central nervous system depression. - Opioids: heightened risk of respiratory depression and profound sedation. - Other benzodiazepines: cumulative sedative effects. - Barbiturates: enhanced CNS depression leading to profound sedation.

Moderate Interactions (Monitor Closely): - SSRIs or other antidepressants: possible increased sedation. - Antihistamines: additive drowsiness. - CYP3A4 inhibitors (e.g., ketoconazole): may raise bromazepam plasma concentrations.